Login
Coverage Universe
Drugs Covered:
3,551
Catalysts Covered:
4,278
Revenue Models:
424
Companies Covered:
864
Companies Evaluated:
28
>>
Advanced Catalyst Search
<<
>>
Advanced Drug Search
<<
>>
Advanced Event Search
<<
Search
Catalysts
Drug Profiles
Impact Events
Company Profiles
Target
Indication
Sample Reports
Special Reports
06/25/09
2009 Post-ASCO Report
05/31/09
2009 ASCO Weekend Update
05/28/09
2009 Pre-ADA Report
05/14/09
2009 Pre-ASCO Report
04/09/09
Diabetes Regulatory Update
03/24/09
Diabetes Approval Timing Update
02/06/09
2009 BioMedTracker Outlook Report
12/18/08
2008 Post-ASH Report
More...
Event Alerts
Date
Lead
Company
Event
Type
Approval
Change
Approval
Likelihood
07/02/09
Lundbeck (LUN:DC)
Lu AA24530 for Major Depressive Disorder (MDD)
Subscribers Only
Subscribers Only
Subscribers Only
07/02/09
Sanofi-Aventis (SNY)
Multaq for Dysrhythmia (Arrhythmia)
Subscribers Only
Subscribers Only
Subscribers Only
07/02/09
Elan (ELN)
Bapineuzumab (IV and SQ) for Alzheimer's Disease (AD)
Subscribers Only
Subscribers Only
Subscribers Only
07/02/09
Roche (ROG:VX)
Lucentis for Retinal vein occlusion (RVO)
Subscribers Only
Subscribers Only
Subscribers Only
07/02/09
Alcon (ACL)
Retaane for Glaucoma
Subscribers Only
Subscribers Only
Subscribers Only
Expected
Date Range
Lead
Company
Drug
Expected
Catalyst
Now - 07/05/09
Subscribers Only
Subscribers Only
Trial Data - Updated Results
07/09/09
Subscribers Only
Subscribers Only
Company - Earnings Announcement
07/09/09
Subscribers Only
Subscribers Only
Company - Earnings Announcement
Now - 07/10/09
Subscribers Only
Subscribers Only
Regulatory - PDUFA/Approval Decision (US)
Now - 07/10/09
Subscribers Only
Subscribers Only
Regulatory - Meeting with FDA
Questions?
Email
Customer Support
Privacy Policy
Important Legal Disclosure
Copyright © 2009 Sagient Research Systems, Inc. All rights reserved.